JMP Securities Reaffirms Market Perform Rating for LAVA Therapeutics (NASDAQ:LVTX)
JMP Securities reaffirmed their market perform rating on shares of LAVA Therapeutics (NASDAQ:LVTX – Free Report) in a research note issued to investors on Thursday,Benzinga reports. Separately, HC Wainwright restated a “neutral” rating and set a $1.50 price objective on shares of LAVA Therapeutics in a research report on Monday, March 31st. Five equities research […]
JMP Securities reaffirmed their market perform rating on shares of LAVA Therapeutics (NASDAQ:LVTX – Free Report) in a research note issued to investors on Thursday,Benzinga reports. Separately, HC Wainwright restated a “neutral” rating and set a $1.50 price objective on shares of LAVA Therapeutics in a research report on Monday, March 31st. Five equities research […]
